Individuals on Hormone Therapy Breast Cancer Screening Pilot

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT06383026
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
30 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Breast Cancer Screening — DIAGNOSTIC_TEST
    Screening mammography as well as whole breast ultrasound interpreted by BI-RADS.
  • Survey/Interview — OTHER
    A mixed-methods approach including electronic surveys and one on one interviews.
  • Focus Group — OTHER
    A semi-structured focus group with open-ended questions that explores faculty and staff experiences in a breast cancer screening program for individuals on hormone therapy.

Study Details

This investigation is a prospective breast cancer screening study open to all individuals on hormone therapy. Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with hormone therapy and family cancer history and 2) investigate individuals on hormone therapy perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening.

Key Dates

Start date
Apr 17, 2024
Status verified
Sep 2025
Primary completion
Dec 31, 2027
Completion
Feb 29, 2028

Study Design

Enrollment
130 participants (estimated)

Arms

  • Arm: Individuals on Hormone Therapy
    Breast imaging data in the form of standard screening mammography in addition to screening whole breast ultrasound will be gathered and interpretations will follow the standard Breast Imaging Reporting and Data Systems. Insight on the perceptions and experiences of being involved in a breast cancer screening program will be gathered.
  • Arm: Breast Imaging Stakeholders
    A semi-structure focus group to explore radiology faculty and staff experiences while capturing information on the perceived screening barriers, what support and/or training staff require to ensure patients are treated equitable in the screening process, and areas for providers and healthcare systems to improve breast cancer screening for individuals on hormone therapy.

Primary Outcome Measure

Callback and Biopsy Rates after Breast Cancer Screening [ Time Frame: 3.5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Medical College of WisconsinMilwaukeeWisconsin53226
Chandler S Cortina, MD, MS
[email protected]

Find similar trials in Milwaukee, WI

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Medical College of Wisconsin· Milwaukee, WI

Related Studies